Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Noble renews accreditation status
September 2017
SHARING OPTIONS:

SYKESVILLE, Md.—In mid-July, Noble Life Sciences, a contract research organization providing services to support the development of drugs, vaccines and medical devices, announced that it had been granted a renewal of full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council on Accreditation. Noble was first awarded AAALAC full accreditation in Oct. 10, 1989.
The renewal, which was granted after an extensive on-site assessment and review of the Noble Life Sciences animal care and use program by the AAALAC International Council on Accreditation, comes without any recommendations for improvement from AAALAC International. Accredited organizations are re-evaluated every three years.
 
“We are very proud to be granted renewal of our full accreditation status.  It affirms the dedication of our staff to highest standards of animal care and validates our commitment to industry and regulatory guidelines,” said Srujana Cherukuri, CEO of Noble Life Sciences.  “AAALAC accreditation is a voluntary process by which our program and our staff undergo intense scrutiny, but we see it as a critical part of our assessment program.”
 
Noble Life Sciences is a preclinical contract research organization offering GLP and non-GLP services in both large and small animals. Preclinical development services include pharmacokinetic and pharmacodynamic studies, biodistribution studies, immunization and immunogenicity testing, early safety assessments, reproductive and developmental toxicity testing, analytical and imaging services and preclinical formulation development.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.